1. Home
  2. INFY vs A Comparison

INFY vs A Comparison

Compare INFY & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infosys Limited

INFY

Infosys Limited

HOLD

Current Price

$12.69

Market Cap

49.5B

Sector

Technology

ML Signal

HOLD

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$135.71

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INFY
A
Founded
1981
1999
Country
India
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
49.5B
39.8B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
INFY
A
Price
$12.69
$135.71
Analyst Decision
Hold
Strong Buy
Analyst Count
5
15
Target Price
$14.60
$161.47
AVG Volume (30 Days)
14.6M
2.2M
Earning Date
04-23-2026
05-27-2026
Dividend Yield
3.56%
0.92%
EPS Growth
N/A
3.16
EPS
N/A
1.07
Revenue
N/A
$4,472,000,000.00
Revenue This Year
$2.87
$8.45
Revenue Next Year
$6.67
$6.13
P/E Ratio
$19.11
$127.07
Revenue Growth
N/A
6.43
52 Week Low
$11.56
$108.35
52 Week High
$30.00
$160.27

Technical Indicators

Market Signals
Indicator
INFY
A
Relative Strength Index (RSI) 50.71 76.61
Support Level $12.65 $121.63
Resistance Level $13.04 $137.85
Average True Range (ATR) 0.44 3.63
MACD 0.09 2.39
Stochastic Oscillator 67.06 87.55

Price Performance

Historical Comparison
INFY
A

About INFY Infosys Limited

Infosys is an IT services provider based in Bengaluru, India, with offices in more than 50 countries. The company leverages its offshore outsourcing model to serve clients across different industries, such as financial services and manufacturing. Infosys' IT services offerings include consulting, digital transformation, and business process outsourcing.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: